After down-regulating the expression of ENPP1, the proliferation, migration and invasion of ovarian cancer cells were significantly inhibited, suggesting that ENPP1 could be a potential molecular therapeutic target. This evidence concerns the gene ENPP1 and ovarian carcinoma.